Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML) by Devemy Emmanuelle, Galili Naomi, Raza Azra

Get full text

Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: A case report of sustained hematologic response following an abbreviated exposure by Quddus Fahd, Clima Jessica, Seedham Helen, Sajjad Ghulam, Galili Naomi, Raza Azra

Get full text

Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome by Galili, Naomi, Tamayo, Pablo, Brooks, Margarita R., Brown, Gail, Raza, Azra, Mesirov, Jill P., Botvinnik, Olga B., Brooks, Margarita R.

Get full text

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS) by Raza Azra, Galili Naomi, Mulford Deborah, Smith Scott E, Brown Gail L, Steensma David P, Lyons Roger M, Boccia Ralph, Sekeres Mikkael A, Garcia-Manero Guillermo, Mesa Ruben A

Get full text

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra^®, TLK199), a novel glutathione analog prodrug in patients with... by Burris Howard, Williams Stephanie, Emanuel Peter, Piro Lawrence, Ochoa Leonel, Callander Natalie, Galili Naomi, Raza Azra, Faderl Stefan, Estrov Zeev, Curtin Peter, Larson Richard A, Keck James G, Jones Marsha, Meng Lisa, Brown Gail L

Get full text